A surface glycoprotein (gp57/67) was previously shown to be involved in measles virus (MV) binding and characterized in our laboratory. Here, we described down-regulation of cell surface gp57/67 after infection with MV. This effect is specific for MV since cells infected with canine distemper virus, closely related to MV, did not down-regulate gp57/67. The decrease in cell surface gp57/67 correlated with expression of MV glycoproteins and more particularly with the expression of MV haemaggluttinin (MV-H). Indeed, expression of MV-H after infection with a vaccinia virus recombinant coding for MV-H was necessary and sufficient to induce down-regulation of gp57/67. Kinetics of cell surface expression of MV-H and gp57/67 showed that the degree of down-regulation was correlated with the amount of MV-H expressed by infected cells. Experiments using antibody-prelabelled gp57/67 and indirect immunofluorescence microscopy allowed us to follow the fate of gp57/67 and showed that down-regulation was occurring by rapid internalization of gp57/67 from the cell surface. These results provide additional evidence that the gp57/67 molecule is closely associated with the pathway of MV infection and also reveal a phenomenon which may be related to viral pathogenesis and persistence.
Introduction
Measles virus (MV) is responsible for an acute respiratory tract infection and is among the primary causes of infant mortality in under-developed countries (Bloom, 1989) . On rare instances, persistent infection can lead to subacute sclerosing panencephalitis or measles inclusion body encephalitis, lethal disorders of the central nervous system.
MV, an enveloped negative-strand RNA virus, contains two glycoproteins, haemagglutinin (H) and fusion protein (F), responsible for binding to the cellular receptor and inducing fusion of viral and cellular membranes. Infection is initiated by attachment of the virus to the host cell via a specific receptor. The virus then fuses at the cell surface releasing the nucleocapsid into the cytoplasm. Little is known about the exact molecular mechanisms of binding and fusion and even less about the fate of the MV receptor during infection. The only known hosts for MV are humans although the virus can infect and induce disease in some monkey species. We hypothesized that the limited host range of MV infection could be due to the restricted expression of a cell surface receptor (Naniche et al., 1992) . In the same report we showed that MV only binds to human and simian cells and not to murine cells. We then isolated a monoclonal antibody (MCI20.6) which inhibits MV binding to host cells and prevents the viral cytopathic effect in vitro. Biochemical characterization identified the cell surface molecule recognized by the antibody MCI20.6 as a glycoprotein, present only on human and simian cells, with an apparent M r of 57K to 67K depending on the cell type.
The measles virus receptor is responsible for initiation of infection; however, its continuing presence may determine the fate of viral infection. Thus it has been suggested that removal of the human parainfluenza virus 3 (HPIV3) receptor during infection can prevent cell-cell fusion and lead to persistent infection (Moscona & Peluso, 1992) . Studies have also shown that CD4, the receptor for human immunodeficiency virus is downregulated from the cell surface by several mechanisms (Hoxie et al., 1986; Crise et al., 1990; Garcia & Miller, 1991) . Regulating the receptor at the cell surface may therefore be an important mechanism involved in viral pathogenesis. In this report we show that MV infection induces down-regulation of the cell surface expression of a putative MV receptor, gp57/67. This phenomenon correlates with MV-H surface expression and results in internalization of cell surface gp57/67.
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Methods
Cells, viruses and antibodies. All cell lines were grown in Dulbecco's modified Eagle's MEM supplemented with 6 % fetal calf serum (FCS), 10 mM-HEPES, 2 mM-glutamine, 5 × 10 -5 M-2-mercaptoethanol and 50 gg/ml gentamicin. Human epithelial (HeLa) and T cell (Jurkat) lines were used in the experiments.
The Halle strain of MV and the Onderstepoort strain of canine distemper virus (CDV) were grown in the African green monkey kidney Vero cell line. Supernatant from the infected Vero cells was then used for these experiments. Vaccinia virus recombinants coding for either MV-H (VV-H) or -F (VV-F) proteins have previously been described (Drillien et al., 1988) . Cells were infected with MV, CDV or vaccinia virus recombinants at 1 p.f.u./ceU. Fluorescence-activated cell sorting analyses were performed 36 h post-infection (p.i.) for MV and CDV and 4 to 5 h p.i. for vaccinia virus recombinants unless otherwise indicated.
MCI20.6 anti-gp57/67 antibody was recently described (Naniche et al., 1992 ), antibodies recognizing MV-H and -F glycoproteins and CDV-H and -F antibodies have previously been described (Giraudon & Wild, 1985; Malvoisin & Wild, 1990; (}rvell et al., 1985) . CD63, CD47 and CD14 antibodies were kindly provided by S. Sealand (Lyon, France), and anti-HLA class I antibodies were purchased from Dakopatts.
Flow cytometry. Cells (3 x 105) were incubated for 30 min at 4 °C with antibody in 100 gl PBS containing 1% BSA and 0.1% NaN 3. Cells were then washed three times in the PBS solution and incubated with a 1 : 150 dilution of fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse immunoglobulin (Zymed Laboratories) in 100 gl PBS for 30 min at 4 °C. After three washes, cells were fixed in 1% paraformaldehyde and flow cytometric analyses were performed on a FACScan (Becton-Dickinson).
Indirect immunofluorescence microscopy. HeLa cells were grown on coverslips and infected with vaccinia or vaccinia recombinant viruses. The cells were fixed in PBS containing 2 % paraformaldehyde and 0.1% glutaraldehyde for 15 rain at room temperature. For intracellular staining, the cells were fixed and permeabilized in 1% Triton X-100 for 5 rain. Saturation and reduction of free aldehyde groups were performed by incubating the fixed cells in PBS/0.1 M-glycine for 10 rain followed by PBS containing 1 mg/ml NaBH 4 for 10 min. After a series of washes in PBS, cells were incubated for 30 min with purified antibody diluted in PBS/0.2 % gelatin. After four washes in PBS, cells were incubated with a 1:200 dilution of rhodamine-conjugated donkey anti-mouse immunoglobulin (Jackson Immunoresearch). After 30 min incubation, cells were washed extensively in PBS and coverslips were mounted on slides for analysis on an Olympus AH-2 fluorescence microscope. All incubations were carried out at room temperature.
Results
Infection of Jurkat cells with MV induces downregulation of surface gp57/67
In order to investigate the effect of MV infection on the cell surface expression of the putative MV receptor gp57/67, Jurkat cells were infected with MV (1 p.f.u./cell), and at 36 h p.i. immunofluorescence was monitored by flow cytometry using the MCI20.6 antibody. The cell surface expression of gp57/67 in MVinfected cells decreased by about 70 % as compared to that found in uninfected cells. This effect was specific for MV since after infection with CDV, which is closely related to MV, viral proteins were expressed but no difference in cell surface expression of gp57/67 was observed ( Fig. 1 a) . Down-modulation of cell surface gp57/67 was detected as early as 15 h p.i. and correlated with expression of MV glycoproteins (Fig. 1 b) .
MV-H is necessary and sufficient to down-regulate cell surface gp57/67 specifically
To determine whether either MV-H or MV-F is involved in inducing down-regulation of cell surface gp57/67, HeLa or Jurkat cells were infected with vaccinia virus recombinants coding for either the MV-H or -F (VV-H and VV-F, respectively). Cells were infected at 1 p.f.u./cell and surface antigen expression was studied by flow cytometry 5 h p.i. At this time, cells expressed the MV-H or -F glycoproteins, but only those infected with VV-H showed decreased surface expression of gp57/67. Cells infected with VV-F or with wild-type vaccinia virus expressed the same amount of surface gp57/67 as uninfected cells (Fig. 2) . This shows that the downmodulation effect is mediated by the MV-H.
To ensure that the down-regulation of cell surface gp57/67 induced by MV-H is specific for this glycoprotein, the expression of other surface markers was analysed in cells infected with wild-type vaccinia virus or VV-H recombinant. The surface expression of four proteins (HLA class I, CD63, CD47 and CD14) was analysed by flow cytometry and found to be unaffected after infection with VV-H or wild-type vaccinia virus (Fig. 3) .
Surface gp57/67 is internalized as MV-H is expressed
The results presented thus far shown an effect of MV-H on gp57/67 disappearance from the cell surface. In order to differentiate between retention of newly synthesized gp57/67 and internalization of pre-existing gp57/67, cells were preincubated with MCI20.6 at 4 °C, washed, infected and incubated at 37 °C. The level of cell surface expression ofMCI20.6-prelabelled gp57/67 was assessed at various times by immunofluorescence and flow cytometry after labelling with FITC-conjugated antimouse IgG at 4 °C. Fig. 4 (a) shows that in uninfected or wild-type vaccinia virus-infected cells MCI20.6-labelled gp57/67 decreased slowly over 5 h. In cells infected with VV-H however, MCI20.6-1abelled gp57/67 started to disappear rapidly 2 to 3hp.i., as soon as MV-H appeared at the cell surface and the degree of downmodulation was correlated with the amount of MV-H expressed by infected cells (Fig. 4b) . This rapid disappearance suggests that surface gp57/67 is internalized or shed from the cell surface. Cell surface gp57/67 expression was slightly decreased at 2 h p.i. yet surface MV-H was not detected until 3 h p.i. This could be the result of the disappearance of MV-H along with gp57/67 which would render MV-H undetectable until an excess of MV-H was reached. Alternatively, the sensitivity of detection for the two antibodies (anti-H and MCI20.6 anti-gp57/67) may be different.
To determine whether the disappearance of gp57/67 was due to internalization or to shedding, unlabetled and MCI20.6-prelabelled cells were infected with VV-H and at 5 h p.i. cells were analysed by indirect immunofluorescence microscopy for intracellular expression of unlabelled or MCI20.6-prelabelled gp57/67. The immunofluorescent staining patterns were identical in both cases showing that the MCI20.6 antibody did not interfere with the down-regulation process. In permeabilized uninfected or vaccinia virus-infected cells, intracellular staining of gp57/67 was barely detectable (Fig. 5a, b ). In permeabilized VV-H-infected cells, however, intracellular staining showed scattered aggregates of gp57/67 (Fig. 5c) . These results show that MV-H triggers internalization of gp57/67 from the cell surface.
Discussion
In the present study, we showed that the MV putative receptor gp57/67, recognized by the MCI20.6 antibody, disappears from the surface of host cells after infection with MV. This down-modulation of gp57/67 is specific for MV infection since CDV infection does not affect gp57/67 cell surface expression. Furthermore, when cells are infected with a vaccinia virus recombinant coding for MV-H or MV-F, only MV-H down-modulates gp57/67. This activity is specific for gp57/67 and does not affect cell surface expression of four other membrane glycoproteins. Down-regulation of gp57/67 occurs by internalization and correlates with the level of cell surface expression of MV-H. These results not only provide additional evidence for the role of gp57/67 in MV infection, but reveal a phenomenon which may be related to viral pathogenesis and persistence. Fig. 4 . Disappearance of MCI20.6-labelled gp57/67 from the surface of cells infected with VV-H. Cells were prelabelled with MCI20.6 at 4 °C, left uninfected (/k) or were infected with 1 p.f.u./cell W -w t (VI) or VV-H (O) and incubated at 37 °C. At the times indicated, cells were analysed by flow cytometry for surface expression of gp57/67 prelabelled with MCI20.6 followed by FITC-conjugated goat antimouse IgG (a) and for surface expression of MV-H with anti-H antibody followed by FITC-conjugated goat anti-mouse IgG (b). Results are expressed as the peak fluorescence channel minus background value (without primary antibody).
A relatively well studied example of a virus affecting the expression of its cellular receptor is HIV gpl60-induced down-regulation of CD4. It has been shown that various mechanisms are involved: decreased CD4 mRNA levels (Hoxie et al., 1986) , retention of CD4 in the endoplasmic reticulum by gpl60 (Crise et al., 1990) , internalization of surface CD4 (Cefai et al., 1992) , and down-regulation by nef, an HIV regulatory protein (Garcia & Miller, 1991) . CD4 can also be internalized after phosphorylation which causes dissociation from associated tyrosine kinase p56 lek (Sleckman et al., 1992) . HIV has been shown to cause CD4 phosphorylation (Fields et al., 1988) and to induce internalization of CD4. The redundancy of the mechanisms leading to downmodulation of surface CD4 suggests that a period of decreased cell surface expression of the viral receptor may be important for the life-cycle of the virus.
In the case of MV-H-induced gp57/67 internalization, the mechanism as well as the fate of gp57/67 are unknown. The mechanism may be direct and involve the interaction of gp57/67 and MV-H in the cell surface membrane leading to internalization of the complex, or it may be indirect and triggered by a short-lived interaction between the two proteins or via a third protein leading to phosphorylation or another modification which could then induce internalization of D. Naniche and others gp57/67. The signal for internalization is derived from an interaction with MV-H since in uninfected cells, surface expression of gp57/67 is quite stable. Biochemical cross-linking studies are under way to determine if MV-H and gp57/67 form a complex and whether the interaction is short-lived and triggers gp57/67 internalization or is longer lived and leads to co-internalization of gp57/67 and MV-H. If gp57/67-MV-H complexes are detectable, studies using confocal microscopy will allow us to see whether these complexes are localized in the same cellular endosomal compartment.
It has been shown for several paramyxoviruses that the two viral envelope glycoproteins are necessary for fusion of infected cells leading to syncytium formation (Ebata et al., 1991; Morrison et al., 1991; Hu et al., 1992) . A recent report on HPIV3 showed that its receptor, sialic acid, is also necessary for cell-cell fusion (Moscona & Peluso, 1992) . Indeed, Moscona & Peluso (1992) showed a correlation between removal of viral receptor, in this case by the large amount of neuraminidase provided by the virus, inhibition of cell-cell fusion and establishment of a persistent infection. These persistently infected cells can, however, undergo complete fusion with fresh uninfected cells. Therefore, interaction of the haemagglutinin-neuraminidase glycoprotein with sialic acid is not only necessary for virus binding but is also required to promote membrane fusion. Elimination of the virus receptor from the cell surface seems to favour establishment of a persistent infection.
In the case of measles virus, Hirano (1992) demonstrated that for persistently infected cell lines, cell-cell fusion leading to syncytium formation does not occur unless fresh cells are added to the culture. Wild et al. (1991) showed that expression of both MV glycoproteins at the surface of murine cells is not sufficient to induce cell-cell fusion thus showing that a cellular factor present on human cells is necessary for fusion along with MV-H and -F. Assuming that gp57/67 is this cellular factor, we can speculate that cell-cell fusion may be prevented by its down-regulation on persistently infected cells. Addition of fresh cells would allow fusion between H/F-expressing cells and the fresh receptor-bearing cells as was observed for HPIV3. Hirano (1992) also showed that persistently infected cells can attach to cells infected with 1 p.f.u./cell of a lytic strain of MV (Edmonston strain) only at an early stage of infection (6 h p.i.) but are unable to attach to the same MV-infected cells at a later stage of infection (24 h p.i.). This correlates with our results showing that surface gp57/67 begins to disappear at 15 h p.i. and shows strong down-regulation at 24 h p.i. Moreover, there was an inverse relationship between the efficiency of attachment of the persistently infected cells to the MV-infected cells and the H protein levels on the surface of MV-infected cells before cocultivation. The kinetics of gp57/67 internalization are also inversely proportional to the cell surface expression of MV-H. These results suggest an important role for the MV cellular receptor in syncytium formation and also that at a later stage of lytic infection, or in a persistently infected cell, there is decreased surface expression of the receptor. Thus down-regulating the cell surface expression of the receptor may be an important mechanism involved in establishing persistence.
We are currently studying gp57/67 expression on persistently infected cell lines, and on cells infected with different strains of lytic virus in order to determine the importance of gp57/67 down-regulation in the establishment of a persistent infection. Amino-terminal protein microsequencing and eDNA cloning of gp57/67 are also under way in order to provide the final proof for the MV receptor function of gp57/67.
